Application 214727
- Type
- ANDA
- Sponsor
- NEXUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | POTASSIUM CHLORIDE 10MEQ | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | 14.9MG/ML | No | No |
| 002 | POTASSIUM CHLORIDE 10MEQ | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | 745MG/100ML | No | No |
| 003 | POTASSIUM CHLORIDE 20MEQ | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | 29.8MG/ML | No | No |
| 004 | POTASSIUM CHLORIDE 20MEQ | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | 1.49GM/100ML | No | No |
| 005 | POTASSIUM CHLORIDE 40MEQ | POTASSIUM CHLORIDE | INJECTABLE;INJECTION | 2.98GM/100ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 14789-107 | Potassium Chloride | Potassium Chloride | Nexus Pharamaceuticals Inc. | ANDA | Current |
| 14789-108 | Potassium Chloride | Potassium Chloride | Nexus Pharamaceuticals Inc. | ANDA | Current |
| 14789-109 | Potassium Chloride | Potassium Chloride | Nexus Pharamaceuticals Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 67046 | ORIG | 2021-04-13 |